Along with its devastating well being toll, COVID-19 may result in important monetary prices for individuals needing therapy and for private and non-private payers. This evaluation examines the price of COVID-19 therapy for inpatient care amongst individuals with well being protection by way of massive employers.
It finds that in 2020, COVID-19 hospitalizations value a mean of $41,611, together with a mean out-of-pocket fee of $1,280 for individuals with massive employer protection. In 2020, many personal insurers and employers briefly waived out-of-pocket prices for COVID-19 therapy (that is usually now not the case). For COVID-19 hospitalizations with some cost-sharing expense, a mean of $1,880 was spent out-of-pocket by people with massive employer protection, although COVID-19 hospitalization prices range broadly for sufferers with personal insurance coverage.
This evaluation focuses on individuals with massive employer protection and doesn’t replicate prices for sufferers with Medicaid or Medicare. At the moment, 2020 is the latest yr of accessible knowledge, and hospitalization and different therapy prices could have modified with the introduction of newer therapies.
The evaluation is on the market by way of the KFF-Peterson Well being System Tracker, an internet data hub that displays and assesses the efficiency of the U.S. well being system.